---
title: INTERCEPT Blood System Insights | Economics
description: Economics | Read interesting blog posts focused on the field of blood safety. Find the latest news on the global use of the INTERCEPT™ Blood System and discover the events where the INTERCEPT pathogen inactivation technology will be on display.
---

This site provides INTERCEPT product information for International audiences [Select your region](https://interceptbloodsystem.com/en)

- [English](https://insights.interceptbloodsystem.com)
- [Deutsch](https://insights.interceptbloodsystem.com/de)

[![INTERCEPT Blood System™](https://insights.interceptbloodsystem.com/hs-fs/hubfs/Logo/logo-cerus.png?width=148&height=58&name=logo-cerus.png "INTERCEPT Blood System™")](http://interceptbloodsystem.com/)

- [About](http://interceptbloodsystem.com/about)
- [Insights](https://insights.interceptbloodsystem.com/)
- [Cerus Campus](https://info.interceptbloodsystem.com/cerus_campus)
- [Resources](http://interceptbloodsystem.com/resources)
- [Contact](http://interceptbloodsystem.com/en/contact)
- [Ask an expert](http://interceptbloodsystem.com/en/ask-expert)

- [Blood center](https://interceptbloodsystem.com/en/blood-center)
- [Healthcare professional](https://interceptbloodsystem.com/en/healthcare-professional)
- [General blood safety](https://interceptbloodsystem.com/en/general-blood-safety)

[![Cerus logo](https://insights.interceptbloodsystem.com/hs-fs/hubfs/Logo/logo-cerus-footer.png?width=121&height=30&name=logo-cerus-footer.png "Cerus logo")](http://interceptbloodsystem.com/) 

Menu

# Insights

[Home](https://interceptbloodsystem.com/) » [Insights](https://insights.interceptbloodsystem.com) » Insights Intercept Blood System

### Categories

- [Cerus (17)](https://insights.interceptbloodsystem.com/topic/cerus)
- [Economics (1)](https://insights.interceptbloodsystem.com/topic/economics)
- [Guidelines (1)](https://insights.interceptbloodsystem.com/topic/guidelines)
- [Hospital News (2)](https://insights.interceptbloodsystem.com/topic/hospital-news)
- [Regulations (1)](https://insights.interceptbloodsystem.com/topic/regulations)
- [Transfusion-Transmitted Infections (8)](https://insights.interceptbloodsystem.com/topic/transfusion-transmitted-infections)

see all

## [Economics 06/07/2018 The economics of Double Dose Buffy Coat Platelets For blood centres seeking a cost-effective way to implement INTERCEPTTM pathogen inactivation, double dose buffy coat platelet production may offer a solution. What is a double dose buffy coat platelet unit? A platelet concentrate with sufficient platelet count to result in 2 therapeutic doses after pathogen inactivation with the INTERCEPT Blood System. The double dose buffy coat platelet...](https://insights.interceptbloodsystem.com/the-economics-of-double-dose-buffy-coat-platelets)

- [‹](https://insights.interceptbloodsystem.com/topic/economics/page/1)
- [«](https://insights.interceptbloodsystem.com/topic/economics/page/0)
- [1](https://insights.interceptbloodsystem.com/topic/economics/page/1)
- [›](https://insights.interceptbloodsystem.com/topic/economics/page/0)
- [»](https://insights.interceptbloodsystem.com/topic/economics/page/1)

### Newsletter

Want to stay updated on the latest pathogen inactivation news?  
You can receive our highlights by subscribing to our newsletter.

[Subscribe to our newsletter](https://info.interceptbloodsystem.com/en/newsletter)

### Ask an Expert

Do you have questions about the INTERCEPT™ Blood System, blood safety or blood transfusions? The INTERCEPT team has plenty of knowledge and expertise.

[Ask an Expert](http://interceptbloodsystem.com/ask-expert)

[![Cerus logo](https://insights.interceptbloodsystem.com/hs-fs/hubfs/Logo/logo-cerus-footer.png?width=121&height=30&name=logo-cerus-footer.png "Cerus logo")](http://interceptbloodsystem.com/)

- [Legal Info](http://interceptbloodsystem.com/legal-info)
- [Privacy Policy](http://interceptbloodsystem.com/privacy-policy)
- [Cookies](http://interceptbloodsystem.com/cookies)

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.  
Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions.

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.

© 2023 Cerus Corporation. All Rights Reserved. MKT-EN 00157 v43.0